An addition to the effect of treating co-infections on HIV-1 viral load

The Lancet Infectious Diseases

Volumn 11, Issue 2, 2011, Pages 81-

  Modjarrad, Kayvon ^a   Vermund, Sten H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; PLACEBO;

CD4 LYMPHOCYTE COUNT; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 78751685882     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70013-5     Document Type: Letter

References (2)

1. Modjarrad K, Vermund SH Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010, 10:455-463.
2. Dunne EF, Whitehead S, Sternberg M, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr 2008, 49:77-83.